Clinical trial
Randomized Trial of Risedronate to Prevent Bone Loss in Renal Transplant…
NCT00266708 · Montefiore Medical Center, Other · Completed
Key facts
| NCT number | NCT00266708 |
|---|---|
| Title | Randomized Trial of Risedronate to Prevent Bone Loss in Renal Transplant Recipients. |
| Official title | Randomized Trial of Risedronate to Prevent Bone Loss in Renal Transplant |
| Lead sponsor | Montefiore Medical Center, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Renal Transplant Osteodystrophy |
| Intervention type | Drug |
| Interventions | Risedronate, Placebo |
| Enrollment | 60 |
| Start date | Oct 1, 2002 |
| Primary completion | Jul 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Dec 19, 2005 |
| Last update posted | Mar 1, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: